Home
Terumo Neuro

Terumo Neuro Market Share Analysis for June 2026

Terumo Neuro is a neuroendovascular medical device company that develops minimally-invasive devices for treatment of vascular diseases in the brain. Aneurysm Therapy Solutions, Ischemic Stroke & Carotid Artery Disease Solutions, Neurovascular Malformation Solutions, and Access Products.

Health > Health - Other

Domainterumoneuro.com

Year Founded1997

Employees1001 - 5000

Annual Revenue--

Terumo Neuro

Terumo Neuro (including company regionals)

terumoneuro.com

See more website traffic and engagement information

Total visits to Terumo Neuro's top domains

Understand Terumo Neuro market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

terumoneuro.com16.6K

See more with Sales Intelligence

Avg. visit duration in Terumo Neuro's top domains

Analyze Terumo Neuro engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

terumoneuro.com00:00:23

See more with Sales Intelligence

Avg. pageviews on Terumo Neuro's top domains

See how Terumo Neuro keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

terumoneuro.com1.86

See more with Sales Intelligence

Terumo Neuro top competitors by domain

Top similar sites in June 2026, ranked by their affinity

route92medical.comCompany NameRoute 92 Medical, Inc.Employees51 - 200HQUnited States, California, San MateoAnnual revenue$5M - $10MTotal visits3.6KN/A

Top technologies used by Terumo Neuro

These are the website technologies, by industry, used by Terumo Neuro top domains

Content Management System (2)

Atlassian Cloud

Conversion & Analytics (2)

Google Analytics

eCommerce (2)

FedEx

Email Services (2)

Microsoft Exchange Online

More Technologies

9

See all

News & Signals from Terumo Neuro

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTerumo Group attended event 2025 European Society of Minimally Invasive Neurological Therapy (ESMINT) 17th Annual Congress on Jul 14th '25.MARSEILLE, France, Sept. 3, 2025 /PRNewswire/ - Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced the launch of the Aneurysm Treatment Alliance at the 2025 European Society of Minimally Invasive Neurological Therapy (ESMINT) 17th Annual Congress.

NewsTerumo Group launched real-world US physician preference data for the Sofia 88 neurovascular support catheter at 2025 SNIS annual meeting on Jul 18th '25.Terumo Neuro has unveiled new, real-world US physician preference data for the Sofia 88 neurovascular support catheter at the 2025 SNIS annual meeting.